NCT03676634View on ClinicalTrials.gov

Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

April 25, 2020

Study Completion Date

July 3, 2020

Conditions
Botulism
Interventions
BIOLOGICAL

rBV A/B

Recombinant Botulinum Vaccine A/B, rBV A/B

Trial Locations (2)

43162

Battelle Biomedical Research Center, West Jefferson

94804

California Department of Public Health, Richmond

All Listed Sponsors
lead

California Department of Public Health

OTHER

NCT03676634 - Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG® | Biotech Hunter | Biotech Hunter